1
National Clinical Trial Training Program 2017 2 nd Annual National Clinical Trial Training Program 2017 June 15 Keynote Presentations June 16 Workshops/Training Sessions Institut et hôpital neurologiques de Montréal 3801, rue University, Montréal (Québec) Montreal Neurological Institute and Hospital 3801 University Street, Montreal, Quebec Centre de Communications de Grandpré de Grandpre Communications Centre Investigators, Researchers, Clinical Research Coordinators, and Industry Representatives are invited to register at: neuroevents.mcgill.ca Clinical Trials: the little biotech that could! Dr. Warren Wasiewski BioBlast Pharma How venture capital analyzes asset potential Dr. Mark Riviere TVM Life Science Management Inc. Phase 1 Trial Site Development Dr. Angela Genge Clinical Research Unit, Montreal Neurological Institute and Hospital Central imaging in MS clinical trials Dr. Doug Arnold Montreal Neurological Institute and Hospital, NeuroRx Research Challenges of stem cell trials in neurodegenerative disease Dr. Jonathan Glass Emory ALS Clinic & Emory School of Medicine Antisense oligonucleotides for neurodegenerative disorders Dr. Roger Lane Ionis Pharmaceuticals, Inc. Investigator Sponsored Studies, Driving Science Through Novel Finding Mechanisms Dr. Timothy M Miller Sanofi-Genzyme Consortium approach to clinical trials: benefits & drawbacks Dr. Michael Hill Calgary Stroke Program, University of Alberta Policies in rare diseases Dr. Daniel L Keene Health Canada CRO role in drug development in rare diseases Orphan Disease Programs with Regulatory Authorities Dr. Angela Genge Clinical Research Unit, Montreal Neurological Institute and Hospital 18:00 Restaurant Graziella Study start-up Ethics submissions Budget & Contract Negotiations Health Canada Inspection Readiness Panel Q & A Cognitive Assessments (tbc) Study Coordinator Best Practices Discussion (Part 1) Study Coordinator Best Practices Discussion (Part 2) June 14 - Welcome Event Pointe-à-Callière Museum, Cocktail – Dinatoire + Museum tour
